Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions

Cancer

Volumn 95, Issue 6, 2002, Pages 1234-1238

  Zaak, Dirk ^a   Hungerhuber, Edwin ^a   Schneede, Peter ^a   Stepp, Herbert ^a   Frimberger, Dominic ^a   Corvin, Stefan ^a   Schmeller, Nikolaus ^b   Kriegmair, Martin ^c   Hofstetter, Alfons ^a   Knöchel, Ruth ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b St Johanns Spital   (Austria)

^c Klinikum Ebersberg   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

5 aminolevulinic acid; Bladder carcinoma; Carcinoma in situ; Dysplasia; Fluorescence

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ARTICLE; BLADDER CARCINOMA; CARCINOMA IN SITU; DYSPLASIA; ENDOSCOPY; EXCITATION; FLUORESCENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR; WORLD HEALTH ORGANIZATION;

AMINOLEVULINIC ACID; BIOPSY; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; ENDOSCOPY; HUMANS; PRECANCEROUS CONDITIONS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0037105391     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10821     Document Type: Article

References (25)

1. Intraurothelial lesions of urinary bladder: Morphologic considerations
2. Serial multiple-site biopsies in patients with bladder cancer
3. Current status of urinary cytology in the evaluation of bladder neoplasms
4. The accuracy of urinary cytology in daily practice
5. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence
6. Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: Preliminary results
7. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid-resuits of 1012 fluorescence endoscopies
8. Current status of urinary cytology in the evaluation of bladder neoplasms
9. Natural history of urothelial dysplasia of the bladder
10. Random bladder biopsies and the risk of recurrent superficial bladder cancer-a prospective study in 1026 patients
11. Epidemiology and etiology of premalignant and malignant urothelial changes
12. Unrecognized renal cell carcinoma: Clinical and diagnostic aspects
13. Latent carcinoma of the prostate
14. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ
15. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer
16. Flat intraepithelial lesions of the urinary bladder
17. Occurrence of chromosome 9 in addition to p53 alterations in multifocal dysplasia carcinoma in situ of human urinary bladder
18. Prevention and treatment of urothelial premalignant and malignant lesions
19. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced 5-aminolaevulinic acid
20. Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid
21. Erfahrungen in der 5-Amino-lävulinsäurecystoskopie mit histologischer Absicherung (01/1996-04/1999)
22. Diagnosis and treatment of superficial transitional cell carcinoma of the bladder: Facts and perspectives
23. The relative value of cytometry and cytology in the management of bladder cancer: The Memorial Sloan-Kettering Cancer Center experience